Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment.
about
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceChronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADTreatment guidelines for Alzheimer's disease: redefining perceptions in primary care.APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's diseaseLongitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease.Group-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease.Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 miceUsing mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsEfficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimenProgression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression studyVitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.Frequency and impact of informant replacement in Alzheimer disease research.Acetylcholinesterase inhibition ameliorates deficits in motivational driveThy1-hAPP(Lond/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social functionGenetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission.Neurologic and motor dysfunctions in APP transgenic mice.Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer's disease: Findings of an observational study.Alzheimer's disease and mild cognitive impairmentImpact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis.Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.Inhibition of γ-Secretase Leads to an Increase in Presenilin-1.Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer's disease mice.Identification of Phlogacantholide C as a Novel ADAM10 Enhancer from Traditional Chinese Medicinal Plants.Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression.Postoperative adverse outcomes in surgical patients with dementia: a retrospective cohort study.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease.Synergistic Effect on Neurodegeneration by N-Truncated Aβ4-42 and Pyroglutamate Aβ3-42 in a Mouse Model of Alzheimer's Disease.Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
P2860
Q21195685-84D42803-9CFE-45B6-A781-39D0F580F464Q28547449-557DFDAD-9B93-4C29-8BF5-8809FE7EF1ECQ30443975-01755766-11E6-4918-9ABE-478F7A9C4B98Q30455082-0409189D-C4DA-45F7-93E8-426B799422F3Q30538459-2CE88F56-FCB4-40FC-930B-843AC5E11B57Q30587067-C1AF81F9-4997-4036-8DE7-24277B3FDC1BQ33881832-6DDC7268-5026-45C8-B85A-071F67B584F6Q33938047-65ABC5CD-C8B9-4525-AA75-81216F99D807Q34418781-B6A77204-5D69-4F0A-9196-AEA20224D417Q34655353-A8A8B855-1036-4ADE-88F0-68AE34EF5217Q35004787-C5FF3396-7EF3-47A3-A1CD-C21BF1B4AE96Q35764820-560669CD-23F2-4F3C-B442-93DE48C7D309Q35802122-B12CE0BD-8937-4EDF-99EE-FE2A32CB912AQ35893873-82BCED75-3489-48AC-87F3-886B70EF9BE4Q35937214-9C1F0012-87C8-4BDC-B7B9-C75C8ECB5D78Q36021405-3A48279B-466A-4616-9931-916EE2861EA7Q36347389-9A24C8FA-5BFC-471D-AA48-A3550FCAF240Q36562190-0A79AFB4-2AC7-489F-B339-07AEBB0553ADQ36894385-BDD7CC03-F88C-4771-965D-2E5FAD91613AQ37193026-EC617C29-9507-489C-AF5A-3A1F97F2D013Q37395530-582BFA32-EA06-4B2E-8BC4-229CF4C04571Q37543468-EFFCDC43-2AFA-4C24-BB38-3CFF5752C1E0Q37985523-EC7AE06A-2629-4A4D-A33B-216B8685FB8CQ38641308-793C95A9-4B76-4EEF-B6C6-148D6F06D3BFQ38699010-F73DDEC4-BCAD-458A-BA54-F92E7BF349B4Q41747758-163463DE-3380-42D8-9F2D-7B18C98718CCQ42455350-BC4D1C7C-9B66-48D6-BB69-017535B41A76Q44063954-2264E592-200D-4EB7-BF81-0548396F9333Q46293996-38C991EC-284D-43C7-9B73-6F274813D7C0Q47794929-03752379-C13E-418C-A693-47ED1890AF75Q50926761-D59499E8-8F1D-4DF3-9DF7-82DC89245285Q51760411-EA06F655-6FA6-43FF-8318-9F87EF61B2C7Q53402722-03E52D18-0F3A-4427-8F1F-C9E327972206
P2860
Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Neurobehavioral and neuropsych ...... characteristics and treatment.
@ast
Neurobehavioral and neuropsych ...... characteristics and treatment.
@en
Neurobehavioral and neuropsych ...... characteristics and treatment.
@nl
type
label
Neurobehavioral and neuropsych ...... characteristics and treatment.
@ast
Neurobehavioral and neuropsych ...... characteristics and treatment.
@en
Neurobehavioral and neuropsych ...... characteristics and treatment.
@nl
prefLabel
Neurobehavioral and neuropsych ...... characteristics and treatment.
@ast
Neurobehavioral and neuropsych ...... characteristics and treatment.
@en
Neurobehavioral and neuropsych ...... characteristics and treatment.
@nl
P1433
P1476
Neurobehavioral and neuropsych ...... characteristics and treatment.
@en
P2093
P304
P356
10.1016/S0733-8619(05)70228-0
P577
2000-11-01T00:00:00Z